# Cardoz

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardoz

- Industry: Pharmaceuticals
- Headquarters: Stockholm, Sweden
- Website: www.cardoz.com
- Total disclosed funding: $17M
- Latest round: Series A (Sep 15, 2010)
- Investors on record: 4

## About

Cardoz AB, founded in 2006, is a Stockholm-based pharmaceutical company exploring new medical approaches to treat vascular diseases such as abdominal aortic aneurysm and atherosclerosis. Cardoz is developing anti-inflammatory drugs with unique properties to reduce vascular inflammation.

## Funding rounds

- Series A, Sep 15, 2010, $3.4M — Industrifonden
- Series A, May 10, 2010, $14M — HealthCap, Forbion, Ysios Capital Partners

## Investors

- HealthCap — Series A
- Forbion (https://capitalatlas.ai/funds/forbion) — Series A
- Ysios Capital Partners (https://capitalatlas.ai/funds/ysios-capital-partners) — Series A
- Industrifonden (https://capitalatlas.ai/funds/industrifonden) — Series A
